Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Lessons Cancer Taught Me

October 21st 2018

I'm using the lessons that cancer taught me to move forward in life.

Committee Supports FDA Approval of CT-P10 for Non-Hodgkin Lymphoma Treatment

October 10th 2018

The Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee voted 16-0 in support of the agency granting approval to CT-P10, a biosimilar of Rituxan (rituximab), which is a drug used to treat non-Hodgkin lymphoma.

Words of Advice to Another Caregiver

October 10th 2018

I shared some advice with another soon-to-be caregiver.

FDA Approves Copiktra for Two Types of Blood Cancer

September 25th 2018

The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma.

CURE New Issue Alert: Hematology Special Issue

September 20th 2018

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

John Theurer's 10th Annual Life and Liberty Event Brings Cancer Survivors Together to Celebrate

September 19th 2018

From an inaugural gathering in 2009 that attracted approximately 700 people, the Life and Liberty event has grown in size each year, with more than 4,000 patients in attendance at last September’s celebration. Organizers said about 6,000 were there this year.

The Cutaneous Lymphoma Foundation Builds Bridges to Fight the Disease

September 15th 2018

The Cutaneous Lymphoma Foundation connects patients with guidance and resources for this rare cancer.

From Bedside to Patient to Caregiver: One Oncologist's Story of Each Side of the Cancer Journey

September 14th 2018

Nicholas J. Vogelzang, M.D., FASCO, FACP, has seen cancer through a variety of lenses – from oncologist to patient as well as caregiver – giving him a different perspective than most.

Taking a Shot to Treat Blood Cancers

September 13th 2018

Injectable forms of medication may benefit patients with blood cancers.

A Starting Player for the Houston Texans Is Facing Blood Cancer

September 11th 2018

Team physician James Muntz diagnosed the blood cancer, and Hal then consulted with oncologists at The University of Texas MD Anderson Cancer Center in Houston.

FDA Approves Drug Duo for Waldenstrom's Macroglobulinemia

August 27th 2018

The FDA has approved Imbruvica (ibrutinib) for use in combination with Rituxan (rituximab) as a treatment option across all lines of therapy for patients with Waldenström macroglobulinemia.

Overcoming Immune Exhaustion and Improving Lymphoma Outcomes

August 24th 2018

"One of the big challenges in lymphoma is that many immune cells are present right in the tumor, but somehow those immune cells are not actually killing the tumor cells," explained Stephen M. Ansell, M.D., Ph.D.

Moving On After Cancer Caregiving

August 22nd 2018

Moving on and focusing on your own future after cancer is an important step in the healing process.

The Devil's Food and Really Good Nurses

August 7th 2018

How a cancer patient still made great memories during one of the most challenging times of his life.

It's Just the Butterflies: Time Travel Back to My Cancer Days

July 31st 2018

How just another day at work triggered thoughts of having cancer as a child.

Transitioning From Patient to Survivor

July 31st 2018

You are one person before the diagnosis comes, you are another person during the journey and you are different person when remission is gained. That is not to say that certain pieces of you don't remain, but I feel it nearly impossible to go through this journey unchanged.

When Cancer Clusters, Create a Medical Family Tree

July 28th 2018

Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.

You're the Perfect Fit, Unless You Have to Go to the Doctor

July 27th 2018

Getting a job while having health issues can be a problem, but don't just take my word for it.

Accepting the Harder Reaities of Cancer

July 27th 2018

When dealing with cancer, it's important to know your limits and be OK with them, to focus on the good.

Reframing Cancer: Focus on the "And"

July 24th 2018

Focusing on the "and" instead of the rest

Being 'Completely Normal' After Cancer

July 23rd 2018

Having cancer can change the word "normal" forever.

FDA Approves Nivestym for Acute Myeloid Leukemia and More

July 23rd 2018

The Food and Drug Administration approved Nivestym (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for five eligible indications.

Individuals Affected by Blood Cancer Feel Disease is 'Under Control'

July 11th 2018

A national survey demonstrated shared feelings across all blood cancer types about treatment options and their side effects, as well as other social, financial and emotional aspects.

A Closer Look at Long-Term Outcomes in Young Cancer Survivors

July 10th 2018

The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.

That Dude Is Wired: Seeing Cancer Advancements Over the Years

July 3rd 2018

A look at how one cancer survivor has witnessed life-changing medical advancements over the years.

More Music and Exercise, and Less Smelly People and Social Media

June 27th 2018

Four ways of helping cancer survivors deal with anxiety and depression.

Why are There No Marches, Trending Hashtags or Walkouts?

June 25th 2018

There can be definite struggles for childhood cancer survivors, even many years later.

Improving Clinical and Emotional Outcomes in Patients With Blood Cancers

June 22nd 2018

CURE spoke with the chief medical officer of the Leukemia & Lymphoma Society to hear what she thinks are important next steps in improving patient outcomes.

Under New Management

June 19th 2018

A new expert guideline for managing immunotherapy’s side effects has been released.

FDA Approves Keytruda for Relapsed/Refractory PMBCL

June 13th 2018

The FDA has granted an accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or those who have relapsed after 2 or more prior lines of therapy.